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ABSTRACT 
Objective: Depression is common among type 2 diabetes mellitus (DM2)/coronary heart disease 
(CHD) patients and is associated with adverse health effects. A promising strategy to reduce burden 
of disease is to identify patients at risk for depression in order to offer indicated prevention. This 
study aims to assess the diagnostic accuracy of the Patient Health Questionnaire-9 (PHQ-9) to be 
used as a tool to identify high risk patients. 
Methods: In this cross-sectional study, 586 consecutive DM2/CHD patients aged >18 were recruited 
through 23 general practices. PHQ-9 outcomes were compared to the Mini International 
Neuropsychiatric Interview (MINI), which was considered the reference standard. Diagnostic 
accuracy was evaluated for minor and major depression, comparing both sum- and algorithm based 
PHQ-9 scores. 
Results: For minor depression, the optimal cut-off score was 8 (sensitivity 71%, specificity 71% and 
an AUC of 0.74). For major depression, the optimal cut-off score was 10 resulting in a sensitivity of 
84%, a specificity of 82%, and an AUC of 0.88. The positive predictive value of the PHQ-9 algorithm 
for diagnosing minor and major depression was 25% and 33%, respectively. 
Limitations: Two main limitations apply. MINI Interviewers were not blinded for PHQ-9 scores and 
less than 10% of all invited patients could be included in the analyses. This could have resulted in 
biased outcomes. 
Conclusions: The PHQ-9 sum score performs well in identifying patients at high risk of minor and 
major depression. However, the PHQ-9 showed suboptimal results for diagnostic purposes. 




The presence of minor depression among patients with a chronic disease is high [1, 2]. In type 2 
diabetes mellitus (DM2) and/or coronary heart disease (CHD) patients for example, the 12-month 
prevalence of minor depression ranges between 25-40% [3, 4]. Approximately 40% of these DM2 
and/or CHD patients with depressive symptoms will develop major depressive disorder within two 
years, indicating that the presence of depressive symptoms or minor depression is the most 
important predictor for major depression [3]. 
The yearly prevalence of major depression is comparable in DM2 patients and patients with CHD and 
adds up to about 10 -20 percent, which is considerably high compared to the prevalence of 5% in the 
general Dutch population [1, 3-10]. Major depression among DM2 and/or CHD patients is associated 
with lower quality of life, an increased risk of mortality, poor medication adherence and increased 
health care costs [9, 11-16]. Moreover, once patients are diagnosed with major depression, only 
roughly one third of the associated disease burden can be averted, even when optimal treatment is 
in place [17]. 
These severe consequences of depression underline the importance of correctly identifying minor 
and major depression in patients with DM2 or CHD thereby enabling general practitioners (GP’s) to 
provide suitable depression care. Previous studies have shown that collaborative and stepped care 
programs may successfully prevent the development of major depression in patients with minor 
depression [18, 19]. However, minor depression often remains unrecognized, which hinders 
successful indicated prevention [20, 21]. 
Although there is no evidence supporting the routine screening of all primary care patients for 
depression, general practitioners should be alert to the existence of depression in patients with 
chronic medical conditions such as DM2 and CHD [22]. Thus, GPs have a need for instruments that 
can be efficiently used to identify depression in their patients and to monitor the course of 
depression during treatment. 
Several instruments have been developed over the past years to identify and monitor 
depression[23] and many of them are tested in patients with chronic medical illnesses [24]. One of 
these instruments is the Patient Health Questionnaire-9 (PHQ-9) which is an extensively applied self-
reported questionnaire comprising the nine depression items from the Diagnostic and Statistical 
Manual of Mental Disorders, fourth edition (DSM-IV) [25]. A recent meta-analysis reported good 
diagnostic accuracy of the PHQ-9 for the case identification of major depression in patients with 
chronic medical illness. This meta-analysis identified 6 studies that all used the Diagnosis and 
Statistical Manual of Mental Disorders (DSM) or the International Classification of Diseases (ICD) as 
reference standard. The pooled sensitivity and specificity were 84% and 88%, respectively, and the 
pooled positive and negative likelihood ratios were 6.77 and 0.19, respectively [24]. Another study, 
not included in this systematic review, compared the performance of the PHQ-9 to a diagnosis of 
major depression according to the DSM-IV criteria in clinical outpatients with DM2. Specificity was 
found to be good (80%-87%), but sensitivity was relatively low (58%-76% ). [26]. Additionally, Hadad 
et al found similar results in 2013 in primary care patients with CHD (sensitivity 59-94%, specificity 
84%-95%) [12]. 
However, studies included in the aforementioned meta-analysis were conducted in a very 
heterogeneous group of patients with different chronic physical health problems. Furthermore, to 
our knowledge, no information is available for the performance of the PHQ-9 to detect minor 
depression in DM2 and CHD patients in primary care, which is important because this is one of the 
main risk factors for major depression. Therefore, this study aims to assess the diagnostic accuracy 
of the PHQ-9 to identify minor and major depression in DM2 and CHD patients without known 





This study was conducted alongside the StepDep study; a cluster randomized controlled trial to 
evaluate the cost effectiveness of a stepped-care intervention to prevent major depression in DM2 
and/or CHD patients in primary care. Detailed information on this project can be found elsewhere 
[27]. Data for purposes of the current study were collected using a cross-sectional design in a 
convenience sample from the StepDep study. 
 
Ethical approval 
The study-protocol was approved by the Medical Ethics Committee of the VU University Medical 
Centre. This study was conducted corresponding the principles of the Declaration of Helsinki and the 
Dutch Medical Research Involving Human Subjects Act. 
 
Study population 
The study population was recruited through 23 general practices with 58 GPs and 128,980 enlisted 
patients in the vicinity of Amsterdam and Twente in the Netherlands. All GPs constructed an initial 
list of patients with DM2 and or CHD (angina pectoris, acute myocardial infarction, other/chronic 
ischemic heart disease, coronary sclerosis, previous myocardial infarction) according to the ICPC (n= 
7,534) (International Classification of Primary Care, see Appendix 1) and were requested to exclude 
patients fulfilling the pre-set exclusion criteria. In total, 1,184 patients (16%) were excluded from 
participation by the GP, because they were diagnosed with type 1 diabetes mellitus, 
dementia/Alzheimer, major psychiatric conditions (schizophrenia, bipolar depression, affective 
psychosis, borderline, suicidal attempts), mental retardation, visual impairment, illiteracy, recent 
loss of a significant other, pregnancy, the use of anti-depressants, or not mastering the Dutch 
language (Appendix 1). All remaining individuals (n= 6,350) were invited by mail, through a letter 
from their GP, to complete the written version of the PHQ-9, which was attached to the invitation 
letter. Demographical information such as gender and zip code was collected concurrently with the 
PHQ-9. 
 A total of 2,876 patients (45%) returned the PHQ-9 by mail and of those 1,076 (37%) gave informed 
consent to participate. These patients were approached by telephone for a MINI interview. The 
interviews took place within two weeks after receiving the PHQ-9 and were administered by trained 
interviewers. Patients who responded but did not give informed consent (n=1800) were excluded 
from the study. Figure 1 represents a flowchart of the recruitment of respondents. Another 448 
(41%) patients were excluded because they could not be contacted within two weeks. Additionally, 
thirty-three were excluded of whom five recently lost a significant other, 14 used anti-depressants at 
time of the inclusion, eleven did not have DM2 or CHD, and 15 had incomplete/missing data. Valid 
scores for the final (complete-case) analysis were obtained from 583 patients. 
  





















- Major psychiatric conditions
- Dementia/Alzheimer
- Language problems
- Visual impairments / 
illiteracy
- Type 1 diabetes mellitus
Exclusion
493 (46%)
- Unable to contact 448
- Recent loss of a significant 
other 5
- Use of anti-depressants 14
- Negative on CHD/DM2 11




PHQ-9: The PHQ-9 is a brief instrument for screening and diagnosing depressive symptoms that was 
developed by Kroenke et al. [8]. The continuous sum score can be used for screening purposes while 
the dichotomous algorithm score can be used for diagnostic purposes. The PHQ-9 comprises the 
following nine items which evaluate the presence of one of the nine symptoms of depression based 
on the DSM-IV criteria: (a) depressed mood, (b) anhedonia, (c) trouble sleeping, (d) feeling tired, (e) 
change in appetite or weight, (f) guilt or worthlessness, (g) trouble concentrating, (h) feeling slowed 
down or restless, (i) suicidal thoughts. These nine items have the following answer categories: “not 
at all” (0), “various days” (1), “more than half the days” (2) and “almost every day” (3), resulting in a 
sum score of 0 to 27. The Dutch version of the PHQ-9, which was translated and validated by Zuithof 
et al., was used for the current study [28]. 
Earlier research reported scores in the 5-9 range are considered an indication for minor depression 
while scores of 10 or higher were considered an indication for major depression [8, 25]. Since little is 
known about the most appropriate cut-off score for minor and major depression in this particular 
high risk population this study aims to establish cut-off scores for screening purposes for this group. 
Based on the PHQ-9 algorithm, minor depression is diagnosed when at least one of the essential 
features of major depression (depressive mood/anhedonia) and one, two or three additional 
depressive symptoms occurred in the previous two weeks for more than half the days [8]. Major 
depression is diagnosed when patients score two or more on at least five categories including one of 
the essential features of major depression (depressive mood/anhedonia) in the previous two weeks. 
The PHQ-9 outcomes in the current study were interpreted without knowledge of the results of the 
reference standard. 
 
MINI: The MINI interview was used as reference standard to diagnose depression. The MINI is a 
short structured diagnostic interview to diagnose DSM IV disorders that can be administered by non-
specialized interviewers. Furthermore, the MINI is often used in clinical practice because of its short 
administration time of approximately 15 minutes. Various studies reported positive results regarding 




Both instruments, the PHQ-9 and the MINI, are based on DSM IV criteria and the outcomes will be 
compared in order to assess diagnostic accuracy. Diagnostic accuracy was established in terms of: 
sensitivity/specificity; positive/negative predictive values, likelihood ratios and Receiver Operating 
Characteristic (ROC) curve analysis. 
 
PHQ-9 sum score: Operating characteristics for the continuous sum scores, applied for screening 
purposes, were calculated by conducting ROC curve analysis. The ROC-curve summarizes the true 
positive fraction (sensitivity) on the y-axis as a function of the false positive fraction (1-specificity) on 
the x-axis for diverse cut-off scores. In addition, the area under the curve (AUC) summarizes the 
tests ability in actually discriminating individuals with and without minor/major depression. A 
maximum score of 1 indicates a perfect distinction between the diseased (true-positive fraction = 
100) and the non-diseased (false negative fraction = 0). A rough guide for interpreting the AUC and 
classifying the accuracy of a diagnostic test is as follows: 0.9 – 1 = excellent; 0.8 – 0.9 = good; 0.7 – 
0.8 = fair; 0.6 – 0.7 = poor; 0.5 – 0.6 = fail [31, 32]. In this study, the AUC was calculated based on the 
sum-scores of the PHQ-9. 
 
PHQ-9 algorithm: Test characteristics for diagnostic purposes were calculated using the dichotomous 
algorithm score (Appendix 2). The sensitivity of a test indicates the percentage of people who were 
correctly classified by the test as having the disorder. Specificity refers to the percentage of people 
who were correctly classified by the test as not having the disorder. The likelihood ratio is a measure 
that reveals the likelihood of a positive or negative outcome.  The positive likelihood ratio (LR +) 
indicates the extent to which a disease is more likely in a patient after finding a positive test result. 
The negative likelihood ratio (LR-) indicates the extent to which a disease is less likely with a negative 
test result. Although these test-characteristics may be valuable in clinical decision-making, the prior 
probability of the disease must also be taken into account. A high prevalence will increase the 
positive predictive value (PPV) by influencing the true positive and false positive rates. The negative 
predictive value (NPV), on the contrary, decreases with high prevalences [33]. Therefore, predictive 
values were also estimated. The positive predictive value is the percentage of people with a positive 
test outcome who actually have the disease. The negative predictive value on the contrary is the 
percentage of people with a negative test outcome who do not have the disease [34]. 
SPSS version 21.0 was used to calculate various test characteristics, to plot the corresponding ROC-
curve and to assess the optimal cut-off point by calculating the AUC. As patients who are diagnosed 
with major depression also fulfil the criteria for a minor depression, results are presented for  the 




The mean age of the participating patients was 68.9 years (SD = 9.8), with 61.8% of the sample being 
male. The mean PHQ-9 score was 5.76 (SD = 4.8). Participating practices were located in four 
different locations, namely; Amsterdam (metropolitan area), Hengelo (urban area), Delden and 
Borne (rural area). Baseline characteristics are presented in Table 1. 
 
  

















Operating characteristics for sum-scores of the PHQ-9  
Minor or major depression: Increasing PHQ-9 cut-off scores were associated with decreasing 
sensitivity in diagnosing minor or major depression, while specificity increased (Figure 2).  Similar 
results were found for the positive likelihood ratios, as higher PHQ-9 cut-off scores improved the 
likelihood of a minor or major depression. The negative likelihood decreased with higher cut-off 
scores. The most optimal cut-off score for screening purposes was 8 and resulted in a sensitivity of 
0.71 (95% CI: 0.52-0.84), a specificity of 0.71 (95% CI: 0.67-0.75), a positive predictive value of 0.13 
(95% CI: 0.09-0.19), a negative predictive value of 0.98 (95% CI: 0.95-0.99), a positive likelihood ratio 
of 2.44 (95% CI: 1.89-3.14) and a negative likelihood ratio of 0.41 (95% CI: 0.25-0.70) (Table 2).   
Characteristic N = 583 
Age (Mean, sd)  
Years 68.9 (9.8) 
Gender (n=, %)  
Female 223 (38.2%) 
Male 360 (61.8%) 
PHQ-9 score (mean, sd)  
Range 0-27 5.76 (4.8) 
General practice (n=, %)  
Amsterdam 315 (54.3%) 
Borne 42 (7.2%) 
Delden 23 (3.9%) 
Hengelo 203 (34.6%) 
Table 2 - Test characteristics of the PHQ-9 cut-off scores for diagnosing Minor Depression 
Cut-off 
score 
Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI) Positive LR (95% CI) Negative LR (95% 
CI) 
≥5 0.82 (0.65-0.93) 0.49 (0.44-0.53) 0.09 (0.06-0.13) 0.98 (0.95-0.99) 1.60 (1.34-1.90) 0.36 (0.18-0.76) 
≥6 0.77 (0.58-0.89) 0.55 (0.51-0.59) 0.10 (0.06-0.14) 0.97 (0.95-0.99) 1.70 (1.38-2.09) 0.43 (0.23-0.79) 
≥7 0.71 (0.52-0.84) 0.65 (0.61-0.69) 0.11 (0.07-0.16) 0.97 (0.95-0.99) 2.02 (1.58-2.58) 0.45 (0.27-0.76) 
≥8 0.71 (0.52-0.84) 0.71 (0.67-0.75) 0.13 (0.09-0.19) 0.98 (0.95-0.99) 2.44 (1.89-3.14) 0.41 (0.25-0.70) 
≥9 0.59 (0.41-0.75) 0.76 (0.72-0.79) 0.13 (0.08-0.20) 0.97 (0.94-0.98) 2.45 (1.78-3.36) 0.62 (0.36-0.81) 
(Abbreviations: CI, confidence interval lower limit-upper limit; PPV, positive predictive value; NPV, negative predictive value; LR, 
likelihood ratio) 
 
The area under the curve for the PHQ-9 sum-score when screening for minor or major depression 
was 0.74 (95% CI: 0.67-0.81) suggesting a fair/acceptable test in discriminating between persons 
with and without a diagnosis of minor or major depression (Figure 2) [31]. 
 
Major depression: Results regarding major depression were similar to the results for minor or major 
depression: the sensitivity decreased for higher PHQ-9 scores as the specificity improved and the 
likelihood of a major depression increased similar to higher PHQ-9 scores (Figure 3). The optimal cut-
off score for screening a major depressive disorder was 10 with a sensitivity of 0.84 (95% CI: 0.63-
0.95) and a specificity of 0.82 (95% CI: 0.78-0.85) (Table 3). 
 
  
Table 3 - Test characteristics of the PHQ-9 cut-off scores for diagnosing Major Depression 
Cut-off 
score 
Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI) Positive LR (95% CI) Negative LR (95%CI) 
≥8 0.92 (0.72-0.99) 0.71 (0.67-0.75) 0.13 (0.08-0.18) 1       (0.98-1) 3.21 (2.69-3.82) 0.11 (0.03-0.42) 
≥9 0.88 (0.68-0.97) 0.77 (0.73-0.80) 0.14 (0.09-0.21) 0.99 (0.98-1) 3.78 (3.07-4.65) 0.16 (0.05-0.45) 
≥10 0.84 (0.63-0.95) 0.82 (0.78-0.85) 0.17 (0.11-0.25) 0.99 (0.98-1) 4.55 (3.56-5.81) 0.20 (0.08-0.48) 
≥11 0.80 (0.59-0.92) 0.85 (0.81-0.87) 0.19 (0.12-0.28) 0.99 (0.97-1) 5.19 (3.94-6.84) 0.24 (0.11-0.52) 
≥12 0.76 (0.54-0.90) 0.89 (0.86-0.91) 0.23 (0.15-0.34) 0.99 (0.97-1) 6.84 (4.96-9.44) 0.27 (0.13-0.54) 
(Abbreviations: CI, confidence interval lower limit-upper limit; PPV, positive predictive value; NPV, negative predictive value; LR, likelihood 
ratio) 
 
The area under the curve was 0.88 (95% CI: 0.78-0.98) indicating the sum score of the PHQ-9 is a 
good test for discriminating persons with and without major depression (Figure 3). 
  
Figures 2 and 3 - ROC curves for PHQ-9 summed-score versus MINI outcome for minor or major 
depression and major depression (diagonal segments are produced by ties) 
 
 





Figure 2, Minor or major depression  Figure 3, Major depression 
 
Test characteristics based on the PHQ-9 algorithm  
Minor or major depression: In total, 34 (5.8%) individuals were identified as having minor or major 
depression according to the MINI, of whom 13 (38%) were diagnosed as being depressed using the 
PHQ-9 algorithm (Table 4), leading to a sensitivity of 0.38 (95% CI: 0.23-0.56). Of the 549 persons 
without minor or major depression according to the MINI, 510 (87%) had a negative PHQ-9 
algorithm outcome, which resulted in a specificity of 0.93 (95% CI: 0.90-0.95), a positive predictive 
value of 0.25 (95% CI: (0.15-0.39), a negative predictive value of 0.96 (95% CI: 0.94-0.97), a positive 
likelihood ratio of 5.38 (95% CI: 3.19-.9.08) and a negative likelihood ratio of 0.67 (95% CI: 0.51-
0.87). 
 
Major depression: A total of 25 (4.3%) patients had major depression according to the MINI, while 
43(7.4%) patients were identified as having major depression based on the PHQ-9 algorithm (Table 
4, bold). This resulted in a sensitivity of 0.56 (95% CI: 0.35-0.75), a specificity of 0.95 (95% CI: 0.93-
0.96), a positive predictive value of 0.33 (95% CI: 0.20-0.49), a negative predictive value of 0.98 (95% 
CI: 0.96-0.99), a positive likelihood ratio of10.78 (95% CI: 6.56-17.70) and a negative likelihood ratio 
of 0.46 (95% CI: 0.30-0.72). 
 
Table 4 - crosstable outcomes PHQ-9 algorithm versus MINI 
 MINI positive MINI negative Total 












PHQ-9 positive 13 14 39 29 52 43 
PHQ-9 negative 21 11 510 529 531 540 
Total 34 25 549 558 583 583 
 
In Appendix 3A and 3B, all 2 by 2 classification tables are provided for each algorithm and cut-off 
score on the PHQ-9. 
DISCUSSION 
This study showed that the PHQ-9 sum-score is a valuable tool to identify patients at high risk for 
minor or major depression. The optimal cut-off score for minor or major depression was 8, while the 
most appropriate cut-off score for major depression was 10. However, applying the PHQ-9 algorithm 
for diagnostic purposes resulted in high false positive rates. Thus, a large percentage of respondents 
will be erroneously labeled as having minor or major depression. This is in line with results from 
previous studies evaluating the criterion validity of the PHQ-9 in chronically ill and high risk 
populations [13, 35-37]. 
Previous studies recommended to use a cut-off score of 6 based on a combination of sensitivity and 
specificity when screening for minor or major depression [13, 27] which is substantially lower than 
the optimal cutoff of 8 in our study. A possible explanation for the higher cut-off score we found 
may be due to overlapping symptomatology between DM2/CHD and depression. Thus, DM2/CHD 
related complaints, such as fatigue, are labelled as depressive symptoms and a higher cut-off score is 
then needed to discriminate between individuals with and without depression. Since lower cut-off 
scores are normally used when screening for minor or major depression in patients with DM2 and/or 
CHD, it is quite possible that the prevalence of minor depression is overestimated in this patient 
group [13, 27]. The optimal cutoff of 10 for major depression found in this study is in line with 
previous studies evaluating the diagnostic accuracy of the PHQ-9 for major depression in different 
populations [12, 26, 37]. However, this optimal cut-off score for major depression approaches the 
cut off score for minor or major depression (PHQ-score of 8 or more) in this patient group. This 
raises the question whether the PHQ-9 is specific enough to distinguish minor from major 
depression in this patient group. 
When screening for depression it is important that the number of false positives is relatively low, 
meaning that specificity is more important than sensitivity. However, it is also important to correctly 
identify patients who are in need of care detect a substantial number of new cases, so the 
instrument should also be adequately sensitive [22]. As compared to other depression instruments 
included in a meta-analysis of diagnostic accuracy studies in patients with chronic physical illness, 
the performance of the PHQ-9 in this study was better than for example the Geriatric Depression 
Scale (GDS), General Health Questionnaire (GHQ) and the Hospital Anxiety and Depression Scale 
(HADS), but similar to the PHQ-9 and Beck Depression Inventory (BDI) [24]. 
This study was the first that examined the performance of the PHQ-9 in screening for and diagnosing 
both major- and minor depression among DM2 and/or CHD patients in primary care. Second, The 
MINI interview, which was used as reference standard, is an extensively applied and validated 
instrument for diagnosing depression and can, therefore, be considered a good reference standard. 
Another strength is that we managed to include a large number of patients in comparison with 
previous studies [26, 35]. Finally, this study examined both the sum score and algorithm based PHQ-
9 score which allowed us to make a comprehensive statement about the applicability of the PHQ-9 
in general practice. 
There are several limitations that should be considered when interpreting our results. Firstly, less 
than 10% of the patients who were invited to participate could be included in the analyses. This 
might have resulted in biased outcomes. Possibly, we would have been able to include more patients 
when a longer period between the PHQ-9 and the MINI administration was allowed. However, this 
was considered undesirable because depressive symptoms may have improved or worsened during 
this period which may influence the estimates of sensitivity and specificity as has been shown in an 
earlier study using the PRIME-MD which is comparable to the MINI [38].  Also, no detailed 
demographic and/or clinical information was available on non-responders, due to the ethical and 
privacy restraints. As a consequence we were unable to check for possible selection bias so the 
reported findings cannot be extrapolated to the general population. Although a large percentage of 
patients was not included and limited information was available for the non-responders, the aim of 
this study was to assess the performance of the PHQ-9 in identifying depressive symptoms in a high 
risk population consisting of DM2/CHD patients and for this purpose we consider our findings 
relevant. 
Secondly the MINI-interviewers were not blinded for the PHQ-9 scores and this knowledge may have 
resulted in biased outcomes and, thereby, in an overestimation of sensitivity and specificity. Thirdly, 
the MINI interview assesses the presence of DSM-IV criteria for depression and is based on self-
reported symptoms. Although the MINI is considered a good reference standard, it cannot be 
considered a gold standard to diagnose depression. Fourth, the StepDep study on which the current 
sample was based, was not powered to assess diagnostic accuracy. In this convenience sample, only 
25 cases of major depression as diagnosed by the MINI were identified, which has led to imprecise 
results as indicated by the wide confidence intervals surrounding the estimates. Finally, because of 
privacy legislation in the Netherlands it was unknown whether patients had received a diagnosis or 
received non-pharmaceutical treatment for depression in the past. This could have biased the 
results. Furthermore, information concerning diagnosis of DM2 and/or CHD was not accessible for all 
patients in this study. Therefore it was not possible to present the results separately for DM2, CHD 
and DM2/CHD. However, patients diagnosed with DM2 and/or CHD are regularly seen by their GP in 
the context of cardiovascular risk management and, thus, recommendations regarding the use of the 
PHQ-9 to identify depression in this high-risk population are of practical use to them. 
 
Conclusions 
Our results show that the continuous sum-score of the PHQ-9 in general practice can be properly 
used to identify DM2/CHD patients at high risk of minor- or major depression, but results in a 
considerable number of patients with a false-positive result. Therefore, we recommend that in usual 
practice the PHQ-9 is followed by a formal diagnostic procedure like a diagnostic psychiatric 
interview to establish the presence of minor or major depression. When resources are lacking to 
perform further diagnostics, it is advised to only offer indicated prevention to patients who explicitly 
express disease burden from depressive symptoms and a need for treatment. 
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